Shawn D. Walker, Ph.D.
Affiliations: | 2002 | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Google:
"Shawn Walker"Mean distance: 8.99 | S | N | B | C | P |
Parents
Sign in to add mentorEdward Piers | grad student | 2002 | UBC | |
(A synthetic approach to the variecolin class of sesterterpenoids: Total syntheses of (+/-)-5-deoxovariecolin, (+/-)-5-deoxyvariecolol and (+/-)-5-deoxyvariecolactone. A new cycloheptenone annulation method employing the bifunctional reagent (Z)-5-iodo-1-t) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Maloney AJ, Içten E, Capellades G, et al. (2020) A Virtual Plant for Integrated Continuous Manufacturing of a Carfilzomib Drug Substance Intermediate, Part 3: Manganese-Catalyzed Asymmetric Epoxidation, Crystallization, and Filtration Organic Process Research & Development |
Icten E, Maloney A, Beaver MG, et al. (2020) A virtual plant for integrated continuous manufacturing of a carfilzomib drug substance intermediate. Part 2: enone synthesis via a Barbier-type Grignard process Organic Process Research & Development |
Içten E, Maloney AJ, Beaver MG, et al. (2020) A virtual plant for integrated continuous manufacturing of a carfilzomib drug substance intermediate. Part 1: CDI-promoted amide-bond formation Organic Process Research & Development |
Beaver MG, Shi X, Riedel J, et al. (2020) Continuous Process Improvement in the Manufacture of Carfilzomib, Part 2: An Improved Process for Synthesis of the Epoxyketone Warhead Organic Process Research & Development. 24: 490-499 |
Dornan PK, Anthoine T, Beaver MG, et al. (2020) Continuous Process Improvement in the Manufacture of Carfilzomib, Part 1: Process Understanding and Improvements in the Commercial Route to Prepare the Epoxyketone Warhead Organic Process Research & Development. 24: 481-489 |
Caille S, Cui S, Faul MM, et al. (2019) Molecular Complexity as a Driver for Chemical Process Innovation in the Pharmaceutical Industry. The Journal of Organic Chemistry |
Caille S, Allgeier AM, Bernard C, et al. (2019) Development of a Factory Process for Omecamtiv Mecarbil, a Novel Cardiac Myosin Activator Organic Process Research & Development. 23: 1558-1567 |
Cochran BM, Corbett MT, Correll TL, et al. (2018) Development of a Commercial Process to Prepare AMG 232 Using A Green Ozonolysis-Pinnick Tandem Transformation. The Journal of Organic Chemistry |
Kasparian AJ, Savarin C, Allgeier AM, et al. (2011) Selective catalytic hydrogenation of nitro groups in the presence of activated heteroaryl halides. The Journal of Organic Chemistry. 76: 9841-4 |
Caille S, Crockett R, Ranganathan K, et al. (2011) Catalytic asymmetric synthesis of a tertiary benzylic carbon center via phenol-directed alkene hydrogenation. The Journal of Organic Chemistry. 76: 5198-206 |